跳转至内容
Merck
CN

The first knockin mouse model of episodic ataxia type 2.

Experimental neurology (2014-08-12)
Samuel J Rose, Lisa H Kriener, Ann K Heinzer, Xueliang Fan, Robert S Raike, Arn M J M van den Maagdenberg, Ellen J Hess
摘要

Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise. EA2 is caused by loss-of-function mutations in the CACNA1A gene, which encodes the α1A subunit of the CaV2.1 voltage-gated Ca(2+) channel. To better understand the pathomechanisms of this disorder in vivo, we created the first genetic animal model of EA2 by engineering a mouse line carrying the EA2-causing c.4486T>G (p.F1406C) missense mutation in the orthologous mouse Cacna1a gene. Mice homozygous for the mutated allele exhibit a ~70% reduction in CaV2.1 current density in Purkinje cells, though surprisingly do not exhibit an overt motor phenotype. Mice hemizygous for the knockin allele (EA2/- mice) did exhibit motor dysfunction measurable by rotarod and pole test. Studies using Cre-flox conditional genetics explored the role of cerebellar Purkinje cells or cerebellar granule cells in the poor motor performance of EA2/- mice and demonstrate that manipulation of either cell type alone did not cause poor motor performance. Thus, it is possible that subtle dysfunction arising from multiple cell types is necessary for the expression of certain ataxia syndromes.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
泰莫西芬, ≥99%
Sigma-Aldrich
咖啡因, BioXtra
Sigma-Aldrich
尼莫地平
Supelco
尼莫地平, Pharmaceutical Secondary Standard; Certified Reference Material
尼莫地平, European Pharmacopoeia (EP) Reference Standard